Understanding how X chromosome inactivation affects autoimmune disease in women
Defining the Role of Dynamic X Chromosome Inactivation in Age-Associated B Cells for Female-Biased Systemic Lupus Erythematosus
This study is looking at how the X chromosome might play a role in lupus, a disease that mostly affects women, by checking how certain genes work in immune cells called B cells, to help us understand why more women get this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10914657 on NIH RePORTER |
What this research studies
This research investigates the role of X chromosome inactivation in the development of systemic lupus erythematosus (SLE), a condition that predominantly affects women. It focuses on how the expression of genes on the X chromosome may contribute to the disease, particularly in B cells, which are crucial for immune response. The study examines the dynamic nature of X chromosome inactivation in these cells and how it may be disrupted in individuals with SLE, potentially leading to increased disease activity. By exploring these mechanisms, the research aims to uncover new insights into the sex bias observed in autoimmune diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with systemic lupus erythematosus, particularly those with varying numbers of X chromosomes.
Not a fit: Patients who are male or do not have systemic lupus erythematosus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for women suffering from systemic lupus erythematosus.
How similar studies have performed: While the specific approach of examining dynamic X chromosome inactivation in B cells is novel, related research has shown that understanding X-linked gene expression can provide insights into autoimmune diseases.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lovell, Claudia Darnell — University of Pennsylvania
- Study coordinator: Lovell, Claudia Darnell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.